The sensor* for the ENERZAIR® BREEZHALER® (indacaterol acetate/glycopyrronium bromide/mometasone furoate inhalation powder) device provides real data to support your therapeutic decisions
Only available in combination with the ENERZAIR® BREEZHALER® device.
The BREEZHALER® inhaler will work equally well, with or without the sensor device, and the sensor and app system are part of the same CE-marked Class I medical device system which may be optionally prescribed along with the medicinal product.
Approval has been based on the consistency and uniformity of product quality characteristics. There is no data on the use of the sensor device in the target population.
To learn how to use the sensor and Propeller® mobile app with the ENERZAIR® BREEZHALER® device, click here.
Benefits of the sensor* for the ENERZAIR® BREEZHALER® device
Inhalation confirmation for patients1
Enables patients to access real data, with the option to share this with their healthcare professional to support therapeutic decisions.1
Reminders to support enhanced adherence to medication1
The sensor* for the ENERZAIR® BREEZHALER® device is easily accessible
Available through a simple prescription2
- The first prescription for ENERZAIR® BREEZHALER® should be written to include a sensor. The sensor battery will last for one year from the day of activation. Repeat prescriptions of ENERZAIR®
BREEZHALER® during this time will not require a sensor. The mobile app will remind your patient when they should ask you for a new sensor prescription.3
The patient attaches the sensor* to the ENERZAIR® BREEZHALER® device2
The patient accesses a personalised profile and owns their personal data1
*The Propeller® sensor for the BREEZHALER® device (herein referred to as 'the sensor/the sensor for the BREEZHALER® device') and the Propeller® mobile app are property of Propeller Health®.
Indication: ENERZAIR® BREEZHALER® is indicated as a maintenance treatment for asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and a high dose of an inhaled corticosteroid, who experienced one or more asthma exacerbations in the previous year.2
References
- Propeller Health®, QR Rationale for EU Classification-2017-B 2019-07-24 Update.
- ENERZAIR® BREEZHALER® Summary of Product Characteristics.
- The Propellor Sensor for ENERZAIR® BREEZHALER® Quick Start Guide, UG-NSPK_en-US_1.3.000NT 2020-02-17.